Cerus Corporation

CERS ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $233.8M $201.3M $186.8M $188.3M $159.5M $114.2M $93.8M $76.1M
Cost of Revenue — — — — — $41.2M $33.4M $31.6M
Gross Profit — — — — — $73.1M $60.4M $44.4M
Gross Margin — — — — — 64.0% 64.4% 58.4%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $80.9M $75.9M $75.5M $83.3M $81.3M $67.0M $66.2M $56.8M
Operating Income $-8.7M $-14.2M $-30.1M $-34.1M $-48.9M $-58.3M $-66.2M $-55.0M
Operating Margin -3.7% -7.1% -16.1% -18.1% -30.7% -51.1% -70.6% -72.3%
Interest Expense — — $8.4M $5.8M $4.9M $3.7M $6.1M $4.0M
Pretax Income $-15.3M $-20.8M $-37.3M $-42.3M $-54.1M $-59.6M $-71.0M $-57.3M
Income Tax Expense $354.0K $205.0K $325.0K $488.0K $319.0K $284.0K $263.0K $229.0K
Net Income $-15.6M $-20.9M $-37.5M $-42.8M $-54.4M $-59.9M $-71.2M $-57.6M
Net Margin -6.7% -10.4% -20.1% -22.7% -34.1% -52.4% -76.0% -75.7%
EPS (Basic) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51 $-0.44
EPS (Diluted) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51 $-0.44
Shares Outstanding (Basic) 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M 131.7M
Shares Outstanding (Diluted) 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M 131.7M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →